Elekta AB (EKTA B)-Medical Equipment-Deals and Alliances Profile

Elekta AB (EKTA B)-Medical Equipment-Deals and Alliances Profile


  • Products Id :- GDME1041D
  • |
  • Pages: 85
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Elekta AB (Elekta) is a medical technology company.The company offers image guided and stereotactic clinical solutions, comprehensive information systems and services for the management of brain disorders and improved cancer care. Its major products include Gamma knife and Extend system; stereotactic system; fully integrated stereotactic radiation therapy system; system for volumetric arc modulated therapy (VMAT); image guided radiation therapy (IGRT) systems; advanced digital treatment systems; treatment planning systems; electronic brachy therapy for skin cancer; and automated remote afterloading platform. It also offers oncology information systems for radiation oncology and medical oncology, treatment planning software, cancer registry and soft tissue visualization software, among others. Elekta products find applications the treatment of cancer using radio therapy and in diagnosis and treatment of brain disorders in hospitals, academic institutions, and specialist and satellite clinics throughout the world. The company operates in North America, Europe, the Middle East, Africa and Asia-Pacific. Elekta is headquartered in Stockholm, Sweden.

Elekta AB (EKTA B)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 6

Elekta AB, Medical Equipment, Deals By Year, 2011 to YTD 2017 7

Elekta AB, Medical Equipment Deals By Type, 2011 to YTD 2017 8

Elekta AB, Medical Equipment, Deals By Region, 2011 to YTD 2017 9

Elekta AB, Medical Equipment, Deals By Market, 2011 to YTD 2017 10

Elekta AB, Medical Equipment, Deals Summary, 2011 to YTD 2017 11

Elekta AB, Medical Equipment, Deal Details 13

Asset Purchase 13

Elekta to Acquire Assets of Asesores Electronics Especializados 13

Private Equity 13

Qeep Ventures Completes Acquisition Of 97.5% Stake In Motala Verkstad 13

Partnerships 15

Elekta Enters into Distribution Agreement with Brainlab 15

Elekta Enters into Distribution Agreement with Kobold Medical 15

Elekta Enters into Distribution Agreement with Toshiba Medical Systems for Linear Accelerator 16

Varian Medical Systems Enters Into Integration Agreement With Elekta For VMAT Treatments 17

Philips Enter Into Co-Development Agreement With Elekta And University Medical Center Utrecht 18

Elekta Enters Into Collaboration With Brainlab For Radiosurgery Software 19

Elekta And BrainLAB Enter Into Technology Integration Agreement 20

Elekta Enters Into Agreement With Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital For Cancer Solutions 21

Elekta Enters Into Distribution Agreement With ScandiDos 21

The Paul Scherrer Institute Enters Into Collaboration With Elekta 22

Equity Offering 23

Elekta Announces Private Placement Of Common Stock 23

Debt Offering 24

Elekta Announces Public Offering of Bonds Due 2020 for USD35.3 Million 24

Elekta Announces Public Offering of Floating Rate Bonds Due 2020 for USD82.4 Million 24

Elekta Completes Private Placement Of Convertible Bonds For US$284 Million 25

Asset Transactions 26

Genesis Care Acquires Portfolio Business from Elekta 26

Elekta to Acquire Assets of Asesores Electronics Especializados 27

Equra Health To Acquire 15 Radiation Therapy Systems And Allied Equipment From Elekta 28

Banner MD Anderson Cancer Center Acquires Multiple Elekta Cancer Management Systems 29

Advanced Radiation Therapy Acquires AccuBoost Assets From Elekta 30

Sunquest Information Acquires Anatomic Pathology Information System Business From Elekta For US$32.6 Million 30

Acquisition 31

Elekta Acquires RTA, Medical Technologies Distributor 31

Elekta Acquires Mesi Medikal, Provider of Radiation Oncology Solutions 32

Elekta Acquires Radon, Linear Accelerator Service Company 33

Elekta Completes Acquisition Of Nucletron For US$523 Million 34

Elekta AB-Key Competitors 36

Key Employees 37

Locations And Subsidiaries 38

Head Office 38

Other Locations & Subsidiaries 38

Recent Developments 41

Strategy And Business Planning 41

Jun 22, 2017: Equicare Health and Elekta announce Vendor Interoperability Program partnership 41

Feb 08, 2017: Elekta Partners With ESTRO Cancer Foundation to Increase Radiation Therapy Awareness and Access in Europe 42

Financial Announcements 43

Jun 01, 2017: Elekta: Year-end report May-April 2016/17 43

Mar 01, 2017: Elekta Announces Interim Report May-January 2016/17 45

Dec 01, 2016: Elekta Interim Report May-October 2016/17 47

Sep 01, 2016: Elekta: Interim Report May - July 2016/17 48

Jun 01, 2016: Elekta Announces Year-end report for May - April 2015/16 49

Mar 02, 2016: Elekta Interim report May - January 2015/16 51

Corporate Communications 54

Jun 01, 2017: Peter Gaccione joins Elekta's Executive Management as head of North America 54

May 10, 2017: Elekta appoints Gustaf Salford as Chief Financial Officer 55

Apr 20, 2016: John Lapre to fulfill role as Elekta's Chief Technology Officer 56

Apr 13, 2016: Richard Hausmann Appointed as Elekta's President and CEO 57

Legal and Regulatory 58

Apr 03, 2017: Varian Medical Systems and Elekta Settle Patent Litigation 58

Nov 01, 2016: USITC Finds in Favor of Varian in Patent Dispute on VMAT Technology 59

Oct 31, 2016: USITC publishes initial determination in litigation dispute 60

May 24, 2016: Elekta to pay humediQ EUR 8.9 million in legal dispute 61

Government and Public Interest 62

Feb 03, 2017: Leaders In Cancer Radiotherapy Recognize World Cancer Day Through Elekta Brachytherapy Equipment Donation 62

Nov 18, 2016: Elekta: New Standard of Care Offers Lower Toxicity, Shorter Treatment Times and Improved Cosmetic Outcomes for Women with Early Stage Breast Cancer 63

Product News 64

May 26, 2017: Elekta Radiosurgery Solutions Highlighted at International Stereotactic Radiosurgery Society Congress 64

May 02, 2017: Elekta to Showcase the Latest in Stereotactic Solutions at ESTRO 36 65

Sep 21, 2016: Elekta to Highlight High Definition Dynamic Radiosurgery Solutions for Faster, More Precise Stereotactic Treatments at Astro Annual Meeting 66

Aug 05, 2016: Data presentations at AAPM 2016 highlight potential of Elekta's high-field MR-linac to enable real-time treatment adaptation 67

Jul 26, 2016: Elekta's Monaco 5.11 treatment planning system takes center stage at 2016 American Association of Physicists in Medicine Annual Meeting 68

May 02, 2016: New Data Presented at ESTRO 35 Show Positive Cosmesis and Favorable Late Side Effects After Accelerated Partial Breast Irradiation with Multicatheter Interstitial Brachytherapy 69

Apr 25, 2016: Elekta to demonstrate market-leading radiosurgery solutions and innovations at ESTRO 35 70

Mar 15, 2016: Dutch medical center begins radiosurgery treatments with Elekta's Leksell Gamma Knife Icon 71

Mar 04, 2016: First patient in U.S. treated with Elekta's Leksell Gamma Knife Icon 72

Mar 01, 2016: New Elekta iViewDose Software Designed to Provide an Essential Safety Check for Radiation Therapy 73

Feb 09, 2016: Russian Clinic Uses Gamma Knife to Treat Record Number of Patients with Brain Cancer and Other Cranial Disorders 74

Jan 22, 2016: First Center in Middle East With Elekta's Versa HD Radiotherapy System Begins Treating Cancer Patients 75

Other Significant Developments 76

Jun 26, 2017: Elekta Chooses Brainlab to Distribute Stereotactic Neurosurgical Solutions Within Selected Markets in Europe 76

Jun 20, 2017: Alliance Cancer Care to Upgrade Cancer Care in Southeastern U.S. with Elekta Solutions 77

Dec 30, 2016: Stockholm County Council, New Karolinska Solna and Elekta sign long-term collaboration agreement to advance cancer care 78

Oct 18, 2016: All India Institute of Medical Science expands cancer care with advanced treatment devices from Elekta 79

Jul 18, 2016: Viennese hospitals to improve cancer treatment with Elekta equipment and software 80

May 25, 2016: Elekta wins public tender to deliver advanced cancer care solutions to New Karolinska Solna 81

May 11, 2016: Turkey's Medicana Health Group Invests EUR 10 Million in Elekta Cancer Treatment Equipment 82

Apr 26, 2016: MD Anderson Cancer Center to acquire Elekta linear accelerators and other radiotherapy solutions 83

Jan 12, 2016: Elekta Chooses Qlik Sense Visual Analytics Platform 84

Appendix 85

Methodology 85

About GlobalData 85

Contact Us 85

Disclaimer 85

List of Figures

Elekta AB, Medical Equipment, Deals by Type, 2011 to YTD 2017 1

Elekta AB, Medical Equipment, Deals By Year, 2011 to YTD 2017 1

Elekta AB, Medical Equipment, Deals By Region, 2011 to YTD 2017 1

Elekta AB, Medical Equipment, Deals By Market, 2011 to YTD 2017 1

Elekta AB, Medical Equipment, Deals By Year, 2011 to YTD 2017 7

Elekta AB, Medical Equipment, Deals by Type, 2011 to YTD 2017 8

Elekta AB, Medical Equipment, Deals By Region, 2011 to YTD 2017 9

Elekta AB, Medical Equipment, Deals by Market, 2011 to YTD 2017 10

List of Tables

Elekta AB, Medical Equipment, Key Facts, 2016 1

Elekta AB, Medical Equipment, Deals Summary, 2011 to YTD 2017 1

Elekta AB, Medical Equipment, Deals By Year, 2011 to YTD 2017 7

Elekta AB, Medical Equipment Deals By Type, 2011 to YTD 2017 8

Elekta AB, Medical Equipment, Deals By Region, 2011 to YTD 2017 9

Elekta AB, Deals By Market, 2011 to YTD 2017 10

Elekta AB, Medical Equipment, Deals Summary, 2011 to YTD 2017 11

Elekta to Acquire Assets of Asesores Electronics Especializados 13

Qeep Ventures Completes Acquisition Of 97.5% Stake In Motala Verkstad 13

Elekta Enters into Distribution Agreement with Brainlab 15

Elekta Enters into Distribution Agreement with Kobold Medical 15

Elekta Enters into Distribution Agreement with Toshiba Medical Systems for Linear Accelerator 16

Varian Medical Systems Enters Into Integration Agreement With Elekta For VMAT Treatments 17

Philips Enter Into Co-Development Agreement With Elekta And University Medical Center Utrecht 18

Elekta Enters Into Collaboration With Brainlab For Radiosurgery Software 19

Elekta And BrainLAB Enter Into Technology Integration Agreement 20

Elekta Enters Into Agreement With Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital For Cancer Solutions 21

Elekta Enters Into Distribution Agreement With ScandiDos 21

The Paul Scherrer Institute Enters Into Collaboration With Elekta 22

Elekta Announces Private Placement Of Common Stock 23

Elekta Announces Public Offering of Bonds Due 2020 for USD35.3 Million 24

Elekta Announces Public Offering of Floating Rate Bonds Due 2020 for USD82.4 Million 24

Elekta Completes Private Placement Of Convertible Bonds For US$284 Million 25

Genesis Care Acquires Portfolio Business from Elekta 26

Elekta to Acquire Assets of Asesores Electronics Especializados 27

Equra Health To Acquire 15 Radiation Therapy Systems And Allied Equipment From Elekta 28

Banner MD Anderson Cancer Center Acquires Multiple Elekta Cancer Management Systems 29

Advanced Radiation Therapy Acquires AccuBoost Assets From Elekta 30

Sunquest Information Acquires Anatomic Pathology Information System Business From Elekta For US$32.6 Million 30

Elekta Acquires RTA, Medical Technologies Distributor 31

Elekta Acquires Mesi Medikal, Provider of Radiation Oncology Solutions 32

Elekta Acquires Radon, Linear Accelerator Service Company 33

Elekta Completes Acquisition Of Nucletron For US$523 Million 34

Elekta AB, Key Competitors 36

Elekta AB, Key Employees 37

Elekta AB, Other Locations 38

Elekta AB, Subsidiaries 38

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Elekta AB, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license

Single User License
USD 250 INR 16143
Site License
USD 500 INR 32285
Corporate User License
USD 750 INR 48428

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com